type here...

CATEGORIES

Coronavirus

LATEST

1...345...35Page 4 of 35

TRENDING

EDITORS CHOICE

Covid is Never Going to Be Over. We Need to Plan Accordingly

Robert Turner, Founding Editor -
Is SARS-CoV-2 nothing more than aggressive Influenza, a new breed of Flu. It looks that way and it may be here to stay. We need to deal with that.

Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for?

Medika Life -
Within 24 hours of the first dose of Silmitasertib the patient showed significant clinical improvement and the oxygen requirement was weaned to room air. The patient was discharged from the hospital five days after starting Silmitasertib.

Long COVID-19: What Doctors Want You to Know

Michael Hunter, MD -
Approximately 15 percent of those with a COVID-19 infection will develop long COVID. Long COVID is prevalent and more common among females and older individuals.

Do We Need to ReAssess Our Covid Vaccination and Testing Policies?

Robert Turner, Founding Editor -
Our current Covid Vaccination strategy may lie at the root of the troubles we face in achieving public acceptance of the vaccines. Is it time to reassess how we deliver the vaccine?

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories